vs
ALPHA & OMEGA SEMICONDUCTOR Ltd（AOSL）与Esperion Therapeutics, Inc.（ESPR）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是ALPHA & OMEGA SEMICONDUCTOR Ltd的1.0倍（$168.4M vs $163.8M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs -0.5%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 0.8%）
Alpha & Omega Semiconductor是一家专业功率半导体供应商，主营功率MOSFET、IGBT、模拟芯片及电源管理模块的研发、生产与销售，产品广泛应用于消费电子、工业设备、汽车、通信和计算等领域，业务覆盖全球主要市场。
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
AOSL vs ESPR — 直观对比
营收规模更大
ESPR
是对方的1.0倍
$163.8M
营收增速更快
ESPR
高出144.2%
-0.5%
两年增速更快
ESPR
近两年复合增速
0.8%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $163.8M | $168.4M |
| 净利润 | $-13.8M | — |
| 毛利率 | 21.1% | — |
| 营业利润率 | 70.3% | 50.6% |
| 净利率 | -8.4% | — |
| 营收同比 | -0.5% | 143.7% |
| 净利润同比 | -27.8% | — |
| 每股收益（稀释后） | $-0.46 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AOSLESPR
| Q1 26 | $163.8M | — | ||
| Q4 25 | $162.3M | $168.4M | ||
| Q3 25 | $182.5M | $87.3M | ||
| Q2 25 | $176.5M | $82.4M | ||
| Q1 25 | $164.6M | $65.0M | ||
| Q4 24 | $173.2M | $69.1M | ||
| Q3 24 | $181.9M | $51.6M | ||
| Q2 24 | $161.3M | $73.8M |
净利润AOSLESPR
| Q1 26 | $-13.8M | — | ||
| Q4 25 | $-13.3M | — | ||
| Q3 25 | $-2.1M | $-31.3M | ||
| Q2 25 | $-77.1M | $-12.7M | ||
| Q1 25 | $-10.8M | $-40.5M | ||
| Q4 24 | $-6.6M | — | ||
| Q3 24 | $-2.5M | $-29.5M | ||
| Q2 24 | $-2.7M | $-61.9M |
毛利率AOSLESPR
| Q1 26 | 21.1% | — | ||
| Q4 25 | 21.5% | — | ||
| Q3 25 | 23.5% | — | ||
| Q2 25 | 23.4% | — | ||
| Q1 25 | 21.4% | — | ||
| Q4 24 | 23.1% | — | ||
| Q3 24 | 24.5% | — | ||
| Q2 24 | 25.7% | — |
营业利润率AOSLESPR
| Q1 26 | 70.3% | — | ||
| Q4 25 | -8.4% | 50.6% | ||
| Q3 25 | -2.5% | -11.4% | ||
| Q2 25 | -6.6% | 8.6% | ||
| Q1 25 | -6.5% | -34.0% | ||
| Q4 24 | -3.4% | -6.4% | ||
| Q3 24 | -0.1% | -31.0% | ||
| Q2 24 | -0.9% | 3.5% |
净利率AOSLESPR
| Q1 26 | -8.4% | — | ||
| Q4 25 | -8.2% | — | ||
| Q3 25 | -1.2% | -35.9% | ||
| Q2 25 | -43.7% | -15.4% | ||
| Q1 25 | -6.6% | -62.2% | ||
| Q4 24 | -3.8% | — | ||
| Q3 24 | -1.4% | -57.2% | ||
| Q2 24 | -1.7% | -83.9% |
每股收益（稀释后）AOSLESPR
| Q1 26 | $-0.46 | — | ||
| Q4 25 | $-0.45 | $0.32 | ||
| Q3 25 | $-0.07 | $-0.16 | ||
| Q2 25 | $-2.61 | $-0.06 | ||
| Q1 25 | $-0.37 | $-0.21 | ||
| Q4 24 | $-0.23 | $-0.14 | ||
| Q3 24 | $-0.09 | $-0.15 | ||
| Q2 24 | $-0.09 | $-0.33 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $190.3M | $167.9M |
| 总债务越低越好 | $4.4M | — |
| 股东权益账面价值 | $800.2M | $-302.0M |
| 总资产 | $976.4M | $465.9M |
| 负债/权益比越低杠杆越低 | 0.01× | — |
8季度趋势，按日历期对齐
现金及短期投资AOSLESPR
| Q1 26 | $190.3M | — | ||
| Q4 25 | $196.3M | $167.9M | ||
| Q3 25 | $223.5M | $92.4M | ||
| Q2 25 | $153.1M | $86.1M | ||
| Q1 25 | $169.4M | $114.6M | ||
| Q4 24 | $182.6M | $144.8M | ||
| Q3 24 | $176.0M | $144.7M | ||
| Q2 24 | $175.1M | $189.3M |
总债务AOSLESPR
| Q1 26 | $4.4M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $14.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $26.7M | — |
股东权益AOSLESPR
| Q1 26 | $800.2M | — | ||
| Q4 25 | $818.8M | $-302.0M | ||
| Q3 25 | $834.1M | $-451.4M | ||
| Q2 25 | $822.3M | $-433.5M | ||
| Q1 25 | $886.3M | $-426.2M | ||
| Q4 24 | $902.6M | $-388.7M | ||
| Q3 24 | $895.3M | $-370.2M | ||
| Q2 24 | $891.6M | $-344.2M |
总资产AOSLESPR
| Q1 26 | $976.4M | — | ||
| Q4 25 | $1.0B | $465.9M | ||
| Q3 25 | $1.0B | $364.0M | ||
| Q2 25 | $1.0B | $347.1M | ||
| Q1 25 | $1.1B | $324.0M | ||
| Q4 24 | $1.1B | $343.8M | ||
| Q3 24 | $1.1B | $314.1M | ||
| Q2 24 | $1.1B | $352.3M |
负债/权益比AOSLESPR
| Q1 26 | 0.01× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.03× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $45.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AOSLESPR
| Q1 26 | — | — | ||
| Q4 25 | $-8.1M | $45.2M | ||
| Q3 25 | $10.2M | $-4.3M | ||
| Q2 25 | $-2.8M | $-31.4M | ||
| Q1 25 | $7.4M | $-22.6M | ||
| Q4 24 | $14.1M | $-35.0M | ||
| Q3 24 | $11.0M | $-35.3M | ||
| Q2 24 | $7.1M | $-7.2M |
自由现金流AOSLESPR
| Q1 26 | — | — | ||
| Q4 25 | $-23.1M | — | ||
| Q3 25 | $420.0K | — | ||
| Q2 25 | $-17.2M | — | ||
| Q1 25 | $-1.1M | — | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $4.1M | $-35.5M | ||
| Q2 24 | $-210.0K | $-7.3M |
自由现金流率AOSLESPR
| Q1 26 | — | — | ||
| Q4 25 | -14.2% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | -9.7% | — | ||
| Q1 25 | -0.6% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 2.3% | -68.7% | ||
| Q2 24 | -0.1% | -9.9% |
资本支出强度AOSLESPR
| Q1 26 | — | — | ||
| Q4 25 | 9.2% | 0.0% | ||
| Q3 25 | 5.4% | 0.0% | ||
| Q2 25 | 8.1% | 0.0% | ||
| Q1 25 | 5.1% | 0.0% | ||
| Q4 24 | 4.3% | 0.0% | ||
| Q3 24 | 3.8% | 0.3% | ||
| Q2 24 | 4.5% | 0.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AOSL
暂无分部数据
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
